Nanoplatforms for targeted molecular imaging in living subjects.

Molecular or personalized medicine is the future of patient management and molecular imaging plays a key role towards this goal. Recently, nanoplatform-based molecular imaging has emerged as an interdisciplinary field, which involves chemistry, engineering, biology, and medicine. Possessing unprecedented potential for early detection, accurate diagnosis, and personalized treatment of diseases, nanoplatforms have been employed in every single biomedical imaging modality, namely, optical imaging, computed tomography, ultrasound, magnetic resonance imaging, single-photon-emission computed tomography, and positron emission tomography. Multifunctionality is the key advantage of nanoplatforms over traditional approaches. Targeting ligands, imaging labels, therapeutic drugs, and many other agents can all be integrated into the nanoplatform to allow for targeted molecular imaging and molecular therapy by encompassing many biological and biophysical barriers. In this Review, we will summarize the current state-of-the-art of nanoplatforms for targeted molecular imaging in living subjects.

[1]  A Gh Podoleanu,et al.  Optical coherence tomography. , 2005, The British journal of radiology.

[2]  Ralph Weissleder,et al.  Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle , 2005, Magnetic resonance in medicine.

[3]  Anna A Shvedova,et al.  Nanomedicine and nanotoxicology: two sides of the same coin. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[4]  Arutselvan Natarajan,et al.  Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[6]  C. Mello,et al.  Revealing the world of RNA interference , 2004, Nature.

[7]  J. Peterson,et al.  Contrast-enhanced CT of the liver and spleen: comparison of ionic and nonionic contrast agents. , 1989, AJR. American journal of roentgenology.

[8]  C. Larabell,et al.  Quantum dots as cellular probes. , 2005, Annual review of biomedical engineering.

[9]  David Cosgrove,et al.  Ultrasound contrast agents: an overview. , 2006, European journal of radiology.

[10]  E. Even-Sapir,et al.  Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Linda K. Molnar,et al.  Nanotechnology for cancer diagnostics: promises and challenges , 2006, Expert review of molecular diagnostics.

[12]  Hessel Wijkstra,et al.  Ultrasound imaging and contrast agents: A safe alternative to MRI? , 2006, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[13]  R. Moats,et al.  In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts , 2004, Cancer Research.

[14]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[15]  Jinwoo Cheon,et al.  Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.

[16]  W. Webb,et al.  Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo , 2003, Science.

[17]  Zahi A Fayad,et al.  Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. , 2006, Nano letters.

[18]  Elliot R. McVeigh,et al.  Serial Cardiac Magnetic Resonance Imaging of Injected Mesenchymal Stem Cells , 2003, Circulation.

[19]  N. Pradhan,et al.  Efficient and color-tunable Mn-doped ZnSe nanocrystal emitters: control of optical performance via greener synthetic chemistry. , 2007, Journal of the American Chemical Society.

[20]  Scott E Fraser,et al.  The year(s) of the contrast agent - micro-MRI in the new millennium. , 2003, Current opinion in immunology.

[21]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[23]  S. Kaul,et al.  Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression , 2005, Circulation.

[24]  G. Wolf,et al.  Time course of nodal enhancement with CT X-ray nanoparticle contrast agents: effect of particle size and chemical structure. , 2000, Investigative Radiology.

[25]  Klaas Nicolay,et al.  MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Klaas Nicolay,et al.  Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. , 2006, Nano letters.

[27]  James F. Young,et al.  MicroPET: a high resolution PET scanner for imaging small animals , 1996, IEEE Nuclear Science Symposium Conference Record.

[28]  M. Phelps,et al.  PET: the merging of biology and imaging into molecular imaging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Anant Agrawal,et al.  Quantitative evaluation of optical coherence tomography signal enhancement with gold nanoshells. , 2006, Journal of biomedical optics.

[30]  Chih-Wei Lai,et al.  The empirical correlation between size and two-photon absorption cross section of CdSe and CdTe quantum dots. , 2006, Small.

[31]  Ralph Weissleder,et al.  Emerging concepts in molecular MRI. , 2007, Current opinion in biotechnology.

[32]  John V Frangioni,et al.  Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging. , 2006, Journal of the American Chemical Society.

[33]  Osman Muhammad,et al.  QUANTUM DOTS ARE PHAGOCYTIZED BY MACROPHAGES AND COLOCALIZE WITH EXPERIMENTAL GLIOMAS , 2007, Neurosurgery.

[34]  Ralph Weissleder,et al.  A dual fluorochrome probe for imaging proteases. , 2004, Bioconjugate chemistry.

[35]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[36]  J. G. Miller,et al.  In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[37]  Anna Moore,et al.  In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.

[38]  S. Griffey,et al.  Long-term effect of irradiation on lymph node uptake of interstitially delivered nanoparticulate contrast media. , 2000, Investigative radiology.

[39]  R Weissleder,et al.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.

[40]  Chris Heyn,et al.  In vivo magnetic resonance imaging of single cells in mouse brain with optical validation , 2006, Magnetic resonance in medicine.

[41]  S A Wickline,et al.  Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. , 2000, Investigative radiology.

[42]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[43]  Rajan P. Kulkarni,et al.  Quantum dots are powerful multipurpose vital labeling agents in zebrafish embryos , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[44]  M. Bawendi,et al.  Engineering InAs(x)P(1-x)/InP/ZnSe III-V alloyed core/shell quantum dots for the near-infrared. , 2005, Journal of the American Chemical Society.

[45]  Noriaki Ohuchi,et al.  In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. , 2007, Cancer research.

[46]  R. Weissleder,et al.  Tomographic fluorescence mapping of tumor targets. , 2005, Cancer research.

[47]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[48]  Tetsuro Tanaka,et al.  Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). , 2004, International journal of pharmaceutics.

[49]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[50]  R. Weissleder,et al.  In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. , 2005, Bioconjugate chemistry.

[51]  Weibo Cai,et al.  Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism , 2006 .

[52]  R. Weissleder,et al.  Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. , 2006, Bioconjugate chemistry.

[53]  B. Cornelissen,et al.  A review of small animal imaging planar and pinhole spect Gamma camera imaging. , 2005, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

[54]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[55]  W. Cai,et al.  Multimodality tumor imaging targeting integrin alphavbeta3. , 2005, BioTechniques.

[56]  J. Remy,et al.  Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: prospective evaluation in 60 patients. , 2006, Radiology.

[57]  G. Radda,et al.  Iron Particles for Noninvasive Monitoring of Bone Marrow Stromal Cell Engraftment into, and Isolation of Viable Engrafted Donor Cells from, the Heart , 2006, Stem cells.

[58]  Tim Liedl,et al.  Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. , 2005, Nano letters.

[59]  J. Panda,et al.  The present and future of nanotechnology in human health care. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[60]  Jan Grimm,et al.  An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles , 2006, Nature materials.

[61]  Splenic lymphoma: ferrite-enhanced MR imaging in rats. , 1988, Radiology.

[62]  Andreas Saleh,et al.  In vivo MRI of brain in ̄ ammation in human ischaemic stroke , 2004 .

[63]  S. Gambhir,et al.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.

[64]  G. Denardo,et al.  Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma , 2007, Journal of Nuclear Medicine.

[65]  S. Griffey,et al.  Indirect computed tomography lymphography using iodinated nanoparticles: time and dose response in normal canine lymph nodes. , 1995, Academic radiology.

[66]  W. Webb,et al.  Multiphoton fluorescence excitation: new spectral windows for biological nonlinear microscopy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Weibo Cai,et al.  Are quantum dots ready for in vivo imaging in human subjects? , 2007, Nanoscale research letters.

[68]  Grace Hu,et al.  Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.

[69]  R Weissleder,et al.  Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. , 1988, Radiology.

[70]  Bruno Brochet,et al.  Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging , 2004, Investigative radiology.

[71]  Dwight G Nishimura,et al.  FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents , 2006, Nature materials.

[72]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[73]  E Stride,et al.  Microbubble ultrasound contrast agents: A review , 2003, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[74]  A. Kjaer.  Molecular imaging of cancer using PET and SPECT. , 2006, Advances in experimental medicine and biology.

[75]  M. Bawendi,et al.  Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging , 2003, Molecular Imaging.

[76]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[77]  Bobbi K Lewis,et al.  In vivo trafficking and targeted delivery of magnetically labeled stem cells. , 2004, Human gene therapy.

[78]  Kathryn Sharer,et al.  In vivo detection of single cells by MRI , 2006, Magnetic resonance in medicine.

[79]  R. Weissleder,et al.  Nanoparticles for the optical imaging of tumor E-selectin. , 2005, Neoplasia.

[80]  C Zimmer,et al.  MR imaging of phagocytosis in experimental gliomas. , 1995, Radiology.

[81]  J. Ying,et al.  Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. , 2007, Angewandte Chemie.

[82]  Ann Thayer.  BUILDING UP NANOTECH RESEARCH: Investments in CENTERS AND INSTITUTES underpin interdisciplinary efforts , 2007 .

[83]  Charles Nicholson,et al.  In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[84]  N. Pradhan,et al.  Efficient, stable, small, and water-soluble doped ZnSe nanocrystal emitters as non-cadmium biomedical labels. , 2007, Nano letters.

[85]  Sanjiv S Gambhir,et al.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. , 2006, Nano letters.

[86]  W. Buchberger,et al.  Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gd–DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI) , 2005, Histochemistry and Cell Biology.

[87]  S. Bhatia,et al.  Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.

[88]  Weibo Cai,et al.  A Thiol-Reactive 18F-Labeling Agent, N-[2-(4-18F-Fluorobenzamido)Ethyl]Maleimide, and Synthesis of RGD Peptide-Based Tracer for PET Imaging of αvβ3 Integrin Expression , 2006 .

[89]  Phil G Campbell,et al.  The use of quantum dots for analysis of chick CAM vasculature. , 2007, Microvascular research.

[90]  Stasia A. Anderson,et al.  Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .

[91]  A. Low,et al.  Technology Insight: optical coherence tomography—current status and future development , 2006, Nature Clinical Practice Cardiovascular Medicine.

[92]  S. Griffey,et al.  Iodinated nanoparticles for indirect computed tomography lymphography of the craniocervical and thoracic lymph nodes in normal dogs. , 1994, Academic radiology.

[93]  Younan Xia,et al.  Gold nanostructures: engineering their plasmonic properties for biomedical applications. , 2006, Chemical Society reviews.

[94]  K. Balasubramanian,et al.  Chemically functionalized carbon nanotubes. , 2005, Small.

[95]  K. Eichler,et al.  Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. , 2002, Radiology.

[96]  Kaiyang Li,et al.  Immunofluorescence detection with quantum dot bioconjugates for hepatoma in vivo. , 2007, Journal of biomedical optics.

[97]  Audrey Player,et al.  Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[98]  Kerry K. Karukstis,et al.  Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.

[99]  Antony K. Chen,et al.  Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging , 2006, Annals of Biomedical Engineering.

[100]  Leon Hirsch,et al.  Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer , 2004, Technology in cancer research & treatment.

[101]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[102]  S. Cherry,et al.  Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[103]  Hedi Mattoussi,et al.  Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.

[104]  R. Nelson,et al.  Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging. , 1998, Radiology.

[105]  Sanjiv S. Gambhir,et al.  How molecular imaging is speeding up antiangiogenic drug development , 2006, Molecular Cancer Therapeutics.

[106]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[107]  J. Jakobsen.  Ultrasound contrast agents: clinical applications , 2001, European Radiology.

[108]  Jonathan R. Lindner,et al.  Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to &agr;v-Integrins , 2003, Circulation.

[109]  J. McGahan,et al.  Indirect computed tomography lymphography of subdiaphragmatic lymph nodes using iodinated nanoparticles in normal dogs. , 1995, Academic Radiology.

[110]  Rolf A. Brekken,et al.  Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature , 2007, Clinical Cancer Research.

[111]  Xiaobo Chen,et al.  Semiconductor quantum dots for photodynamic therapy. , 2003, Journal of the American Chemical Society.

[112]  Samuel A. Wickline,et al.  Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis , 2006 .

[113]  Erkki Ruoslahti,et al.  Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[114]  Jayanth Panyam,et al.  Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. , 2006, Journal of nanoscience and nanotechnology.

[115]  T. Mihaljevic,et al.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.

[116]  C. Marx,et al.  Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. , 2000, Radiology.

[117]  Alan P Koretsky,et al.  MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[118]  Weibo Cai,et al.  Semiconductor quantum dots for in vivo imaging. , 2007, Journal of nanoscience and nanotechnology.

[119]  James A J Fitzpatrick,et al.  Sentinel lymph node imaging using quantum dots in mouse tumor models. , 2007, Bioconjugate chemistry.

[120]  B. Ross,et al.  Photonic explorers based on multifunctional nanoplatforms for biosensing and photodynamic therapy , 2007 .

[121]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[122]  P. Alivisatos.  The use of nanocrystals in biological detection , 2004, Nature Biotechnology.

[123]  Richard M. Levenson,et al.  Spectral Imaging and Pathology: Seeing More , 2004 .

[124]  S. Cherry,et al.  Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[125]  Michael A Horton,et al.  Medical nanotechnology in the UK: a perspective from the London Centre for Nanotechnology. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[126]  Richard M Levenson,et al.  Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging. , 2005, Journal of biomedical optics.

[127]  Yoshimi Anzai,et al.  Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. , 2003, Radiology.

[128]  R. Ivkov,et al.  Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy , 2005, Clinical Cancer Research.

[129]  Younan Xia,et al.  Gold nanocages as contrast agents for spectroscopic optical coherence tomography. , 2005, Optics letters.

[130]  Barjor Gimi,et al.  Molecular and functional imaging of cancer: advances in MRI and MRS. , 2004, Methods in enzymology.

[131]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[132]  Garry E. Kiefer,et al.  Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles , 2007 .

[133]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[134]  Jonathan R Lindner,et al.  Molecular imaging with targeted contrast ultrasound. , 2007, Current opinion in biotechnology.

[135]  Vladimir P Torchilin,et al.  Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo , 2005, Nature Medicine.

[136]  E T Ahrens,et al.  Receptor‐mediated endocytosis of iron‐oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging , 2003, Magnetic resonance in medicine.

[137]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[138]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[139]  Zahi A Fayad,et al.  Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.

[140]  Mario Stevenson,et al.  Therapeutic potential of RNA interference. , 2004, The New England journal of medicine.

[141]  M. Prato,et al.  Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.

[142]  W. Cai,et al.  In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin αvβ3 , 2006 .

[143]  J. Caillé,et al.  MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. , 2006, AJNR. American journal of neuroradiology.

[144]  Ű. Langel,et al.  Cell-penetrating peptides: mechanisms and applications. , 2005, Current pharmaceutical design.

[145]  Hui Li,et al.  Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. , 2007, Journal of the American Chemical Society.

[146]  Zhivko Zhelev,et al.  Quantum dots as photosensitizers? , 2004, Nature Biotechnology.

[147]  J. Seppenwoolde,et al.  Lanthanide-loaded liposomes for multimodality imaging and therapy. , 2006, Cancer biotherapy & radiopharmaceuticals.

[148]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[149]  E. Hoffman,et al.  Application of annihilation coincidence detection to transaxial reconstruction tomography. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[150]  P. Dayton,et al.  Targeted imaging using ultrasound contrast agents , 2004, IEEE Engineering in Medicine and Biology Magazine.

[151]  Ralph Weissleder,et al.  Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.

[152]  R Weissleder,et al.  Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent , 1999, Journal of magnetic resonance imaging : JMRI.

[153]  Jinwoo Cheon,et al.  Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.

[154]  Hyuing Zhang,et al.  Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[155]  S. Griffey,et al.  Indirect computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model. , 1996, Academic radiology.

[156]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[157]  V. Ntziachristos.  Fluorescence molecular imaging. , 2006, Annual review of biomedical engineering.

[158]  T. McMurry,et al.  Gadolinium meets medicinal chemistry: MRI contrast agent development. , 2005, Current medicinal chemistry.

[159]  Ű. Langel,et al.  Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. , 2006, Current opinion in pharmacology.